The Shadow Industry Behind Femtech: Why Women's Health Innovation Meets Resistance The struggles of Daye, a femtech company that has pioneered at home HPV and STI detection through its diagnostic tampon, have exposed a pervasive issue in women's health innovation.
Despite achieving significant milestones, including FDA 510(k) clearance for its menstrual tampon and over $28 million in funding, the startup's journey is far from smooth.
One of the most striking aspects of Daye's story is Google's categorization of its diagnostic tampon as a contraceptive.